- Home
- LXRX vs BMEZ Comparison
LXRX vs BMEZ Comparison
Compare LXRX & BMEZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.34
Company Overview
Basic Information| Metric | LXRX | BMEZ |
|---|---|---|
| Founded | 1995 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 990.6M | 925.6M |
| IPO Year | 2000 | 2019 |
Fundamental Metrics
Financial Performance| Metric | LXRX | BMEZ |
|---|---|---|
| Price | $2.34 | $15.56 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.15 | N/A |
| AVG Volume (30 Days) | ★ 2.7M | 141.5K |
| Earning Date | 05-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.78 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $49,803,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 60.24 | N/A |
| 52 Week Low | $1.02 | $13.67 |
| 52 Week High | $2.68 | $15.80 |
Technical Indicators
Market Signals| Indicator | LXRX | BMEZ |
|---|---|---|
| Relative Strength Index (RSI) | 53.49 | 60.57 |
| Support Level | $2.04 | $14.94 |
| Resistance Level | $2.61 | $15.76 |
| Average True Range (ATR) | 0.15 | 0.21 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 65.12 | 66.20 |
Price Performance
Historical Comparison LXRX
BMEZ
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About BMEZ BlackRock Health Sciences Term Trust of Beneficial Interest
BlackRock Health Sciences Term Trust is a closed-end fund focused on the healthcare and health sciences sector. Its investment objectives are to provide total return and income through long-term capital appreciation.